The WorldWide Antimalarial Resistance Network (WWARN) works with partners across the world to optimise the efficacy of antimalarial medicines and treatment regimens - especially for vulnerable groups such as pregnant women, infants and malnourished children. WWARN also engages and works with other disease research communities to replicate this model for other devastating tropical and neglected diseases.
Our international partnerships play an essential role in WWARN’s efforts to combat malaria and track the emergence of antimalarial drug resistance. Through this collaborative approach, the WWARN network will continue to provide valuable evidence to help save more lives and support the global effort to control, eliminate and eventually, eradicate malaria.
Find out more about drug resistant Plasmosdium falciparum and Plasmodium vivax
Watch the video below to find out more about how WWARN are collaborating to combat malaria drug resistance.
What we do:
- Provide the malaria community with a reliable data collection platform to facilitate data sharing, pooled data analyses, and application of these findings to provide evidence for policy makers and drug developers to optimise the therapeutic life of existing and new antimalarial medicines.
- Develop freely available guidance, easily accessible tools, and training materials support researchers in malaria endemic countries in the collection, analysis, interpretation, and dissemination of high quality evidence on antimalarial drug efficacy.
Watch this video about suppporting the fight against malaria drug resistance. "Malaria, until the turn of the century, was really a disaster," begins Professor Kevin Marsh from the University of Oxford, in this video produced in partnership with the by Exxon Mobil Foundation. The video describes the global threat of antimalarial drug resistance and the work WWARN is doing to combat it.
Who we are:
- Our People– WWARN is governed by a Board who oversees WWARN’s activities. The Scientific Advisory Committee guides the scientific pursuits of the Network. The Secretariat manages the day-to-day running of network.
- Scientific Groups – we are comprised of five diverse scientific groups specialising in specific areas of antimalarial drug resistance; Clinical, Pharmacology, In-Vitro, Antimalarial Quality and Molecular.
- Regional centres – the network supports regional efforts to build capacity, provide training and advise to local researchers and healthcare workers. These regional centres are located in Asia, East Africa, West Africa and Latin America.
Find out more about WWARN and how you too can get involved in the partnership.
En savoir plus sur WWARN et comment vous pouvez vous impliquer dans le partenariat.